In the obese trial cohort, 1 mg moved 24-hour heart rate by +0.7 bpm in the first week, essentially placebo. In a healthy lean Phase 1b group, the same dose raised heart rate by about 10 bpm, with a peak near 15 to 20 bpm around days 4 to 6. Lean, younger participants had more reactive heart-rate control than the sedentary, obese, and metabolically stressed trial population
Important Notice GHK-Cu is supplied strictly for research use only
This research peptide is 99% purity
Symptoms include numbness or tingling in hands and feet, weakness, fatigue, and trouble walking
Whether you are using compounded tirzepatide or exploring branded options like Mounjaro or Zepbound through a pharmacy, the goal remains the same: a healthier, more vibrant you